Six‐year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer
- 1 October 1985
- journal article
- clinical trial
- Published by Wiley in World Journal of Surgery
- Vol. 9 (5), 756-764
- https://doi.org/10.1007/bf01655191
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985
- BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUESThe Lancet, 1985
- LONG-TERM SURVIVAL OF WOMEN WITH BREAST CANCERThe Lancet, 1984
- Effect of Adjuvant Therapy in Primary Breast Cancer in Relation to the Estrogen Receptor LevelPublished by Springer Nature ,1984
- Adjuvant chemotherapy and hormonal therapy for operable breast cancer with positive axillary nodesJournal of Steroid Biochemistry, 1983
- IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCERThe Lancet, 1983
- Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.BMJ, 1983
- Adjuvant tamoxifen therapy for early breast cancer: An experimental study with reference to oestrogen and progesterone receptorsBritish Journal of Surgery, 1982
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted TriphenylethylenesNature, 1966